is stdei glp 1 safe glp1-PSM-content – Partnership for Medicines GLP-1 receptor agonists | How

Even though some studies have shown that SGLT2 inhibitors modestly increase HDL cholesterol levels compared with placebo, there are also available data suggesting a small increase in LDL cholesterol [26, 29]

10.1152/ajpendo.00237.2004

Practitioners hesitancy to start new medications due to perceived titration complexity, incomplete understanding of drug interactions, and uncertainty of monitoring tools and goals of care, coupled with a belief that GLP-1R agonists requiring subcutaneous injections would not be well received by patients are major barriers to optimal use

These findings support the idea that some patients may have partial biologic resistance to incretin-based therapies, said Robert Glatter, MD, attending physician in the Department of Emergency Medicine at Lenox Hill Hospital in New York City, and Assistant Professor of Emergency Medicine at Zucker School of Medicine at Hofstra/ Northwell